Renal elimination of a novel and potent α_vβ₃ integrin antagonist in animals

Reference

• ARNDT, P., VOLK, C., GORBOULEV, V., BUDIMAN, T., Popp, C., ULZHEIMER-TEUBER, I., AKHOUNDOVA, A., KOPPATZ, S., BAMBERG, E., NAGEL, G. and KOEPSELL, H., 2001, Interaction of cations, anions, and weak base quinidine with rat renal cation transporter rOCT2 compared with rOCT1. American Journal of Physiology and Renal Physiology, 281, F454—F468.
   Google Scholar
• Boom, S. P. A., MOONS, M. M. and RUSSEL, F. G. M., 1994, Renal tubular transport of cimetidine in the isolated perfused kidney of the rat. Drug Metabolism and Disposition, 22, 148–153.
   Google Scholar
• BURCKHARDT, B. C. and BURCKHARDT, G., 2003, Transport of organic anions across the basolateral membrane of proximal tubule cells. Review of Physiology, Biochemistry and Pharmacology, 146, 95–158.
   PubMed Web of Science ®Google Scholar
• CHA, S. H., SEKINE, T., FUKUSHIMA, J.-I., KANAI, Y., KOBAYASHI, Y., GOYA, T. and ENDUO, H., 2001, Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Molecular Pharmacology, 59, 1277–1286.
   Google Scholar
• Cm, D., SUBRAMANIAN, R., SHOU, M., Yu, X., WALLACE, M. A., BRAUN, M. P., ARISON, B. H., YERGEY, J. L. and PRUEKSARITANON T., 2004, In vitro and in vivo metabolism of a potent and selective integrin c33 antagonist in rats, dogs, and monkeys. Drug Metabolism and Disposition, 32, 848–861.
   PubMedGoogle Scholar
• DEGUCHI, T., OHTSUKI, S., OTAGIRI, M., TAKANAGA, H., ASABA, H., MORI, S. and TERASAKI, T., 2002, Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney, Kidney International, 61, 1760–1768.
   Google Scholar
• DRESSER, M. J., GRAY, A. T. and GIACOMINI, K. M., 2000, Kinetic and selectivity differences between rodent, rabbit and human organic cation transporters (OCT). Journal of Pharmacology and Experimental Therapeutics, 292, 1146–1152.
   PubMed Web of Science ®Google Scholar
• DRESSER, M. J., LEABMAN, M. K. and GIACOMINI, K. M., 2001, Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. Journal of Pharmacology Science, 90, 397–421.
   PubMed Web of Science ®Google Scholar
• FORD, J. M. and HATT, W. H., 1990, Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacology Reviews, 42, 155–199.
   PubMed Web of Science ®Google Scholar
• HARTMAN, G. D. and DUGGAN, M. E., 2000, Alpha (v) beta (3) integrin antagonists as inhibitors of bone resorption. Expert Opinion on Investigational Drugs, 9, 1281–1291.
   PubMed Web of Science ®Google Scholar
• HUTCHINSON, J. H., HALCZENKO, W., BRASHEAR, K. M., BRASHEAR, K. M., BRESLIN, M. J., COLEMAN, P. J., DUONG, L. T., FERNANDEZ-METZLER, C., GENTILE, M. A., FISHER, J. E., HARTMAN, G. D., HUFF, J. R., KIMMEL, D. B., LEU, C.-T., MEISSNER, R. S., NAGY, R., PENNYPACKER, B., PERKINS, J. J., PRUEKSARITANONT, T., RODAN, G. A., VARGA, S. L., WESOLOWSKI, G. A., ZARTMAN, A. E., RODAN, S. B. and DUGGAN, M. E., 2003, Nonpeptide 043 Antagonists. Part X: The in vitro and in vivo evaluation of a potent 007133 antagonist for the prevention and treatment of osteoporosis. Journal of Medical Chemistry, 46, 4790–4798.
   Google Scholar
• JARIYAWAT, S., SEKINE, T., TAKEDA, M., APIWATTANAKUL, N., KANAI, Y., SOPHASAN, S. and ENDOU, H., 1999, The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. Journal of Pharmacology and Experimental Therapeutics, 290, 672–677.
   PubMed Web of Science ®Google Scholar
• J1, L., MASUDA, S., SAITO, H. and INui, K.-I., 2002, Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy. Kidney International, 62, 514–524.
   Google Scholar
• KHAMDANG, S., TAKEDA, M., SHIMODA, M., NOSHIRO, R., NARIKAWA, S., HUANG, X.-L., ENOMOTO, A., PIYACHATURAWAT, P. and ENDOU, H., 2004, Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine. Journal of Pharmacology Science, 94, 197–202.
   Google Scholar
• KUSUHARA, H., SEKINE, T., UTSUNOMIYA-TATE, N., TSUDA, M., KOHMA, R., CHA, S. H., SUGIYAMA, Y., KANAI, Y. and ENDOU, H., 1999, Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain, Journal of Biological Chemistry, 274, 13675–13680.
   Google Scholar
• LIN, J. H., Los, L. E., ULm, E. H. and DUGGAN, D. E., 1988, Kinetic studies on the competition between famotidine and cimetidine in rats: evidence of multiple renal secretory systems for organic cations. Drug Metabolism and Disposition, 16, 52–56.
   PubMed Web of Science ®Google Scholar
• MASEREEUW, R. and RUSSEL, F. G. M., 2001, Mechanisms and clinical implications of renal drug excretion. Drug Metabolism Reviews, 33, 299–351.
   PubMed Web of Science ®Google Scholar
• MILLER, W. H., BONDINELL, W. E., COUSINS, R. D., ERHARD, K. F., JAKAS, D. R., KEENAN, R. M., Ku, T. W., NEWLANDER, K. A., Ross, S. T., HALTIWANGER, R. C., BRADBEER, J., DRAKE, F. H., GOWEN, M., HOFFMAN, S. J., HWANG, S.-M., JAMES, I. E., LARK, M. W., LECHOWSKA, B., RIEMAN, D. J., STROUP, G. B., VASKO-MOSER, J. A., ZEMBRYKI, D. L., AZZARANO, L. M., ADAMS, P. C., SALYERS, K. L., SMITH, B. R., WARD, K. W., JOHANSON, K. 0. and HUFFMAN, W. F., 1999, Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model. Bioorganic and Medical Chemistry Letters, 9, 1807–1812.
   Google Scholar
• MURPHY, M. G., CERCHIO, K., STOCH, A., GOTTESDIENER, K., Wu, M. and RECKE R., 2004, Effect of MRL123, an a Vfl3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. Paper presented at the American Society for Bone and Mineral Research 26th Annual Meeting, 1–5 October 2004, Seattle, Washington, USA.
   Google Scholar
• NAGATA, Y., KUSUHARA, H., ENDOU, H. and SUGIYAMA, Y., 2002, Expression and functional characterization of rat organic anion transporter 3 (r0at3) in the choroids plexus. Molecular Pharmacology, 61, 982–988.
   PubMed Web of Science ®Google Scholar
• PRITCHARD, J. B. and MILLER, D. S., 1993, Mechanisms mediating renal secretion of organic anions and cations. Physiology Reviews, 73, 765–796.
   PubMed Web of Science ®Google Scholar
• PRUEKSARITANONT, T., FERNANDEZ-METZLER, C., MENG, Y., BARRISH, A., HALCZENKO, W., RODAN, S., HUTCHINSON, J., DUGGAN, M. and LIN, J. H., 2004, Disposition of a novel and potent 043 antagonist in animals, and extrapolation to man. Xenobiotica, 34, 103–115.
   PubMedGoogle Scholar
• PRUEKSARITANONT, T., CHEN, M. L. and CHIOU, W. L., 1984, Simple and micro high-performance liquid chromatographic method for simultaneous determination of p-aminohippuric acid and iothalamate in biological fluids. Journal of Chromatography and Biomedical Applications, 306, 89–97.
   Google Scholar
• PRUEKSARITANONT, T., MENG, Y., MA, B., LEPPERT, P., HOCHMAN, J., TANG, C., PERKINS, J., ZRADA, M., MEISSNER, R., DUGGAN, M. and LIN, J. H., 2002, Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of 003 antagonists in rats: limited role of P glycoprotein. Xenobiotica, 32, 207–220.
   PubMed Web of Science ®Google Scholar
• REYES, J. L., MELENDEZ, E., ALEGRi A. and JARAMILLO-JUAREZ, F., 1998, Influence of SCX differences on the renal secretion of organic anions. Endocrinology, 139, 1581–1587.
   Google Scholar
• RODAN, S. B., DUONG, L. T., DUGGAN, M. E., FISHER, J. E., GENTILE, M. A., FERNANDEZ-METZLER, C., HALCZENKO, W., HARTMAN, G., HUTCHINSON, J. H., LEU, C.-T., LIPFERT, L., NAGY, R. M., PENNYPACKER, B., PRUEKSARITANONT, T., SEEDOR, J. G., WESOLOWSKI, G., KIMMEL, D. B. and RODAN, G. A., 2002, A potent antagonist of 0c,,133 integrin is a powerful inhibitor of bone resorption in vivo. Bone Mineral Research, 17, S198.
   Google Scholar
• URAKAMI, Y., OKUDA, M., MASUDA, S., SAITO, H. and INui, K.-I., 1998, Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. Journal of Pharmacology and Experimental Therapeutics, 287, 800–805.
   Google Scholar
• YAMAGUCHI, H., YANO, I., YANO, I., HASHIMOTO, Y. and INui, K -I., 2000, Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2. Journal of Pharmacology and Experimental Therapeutics, 295, 360–366.
   Google Scholar
• YAMAOKA, K., TANIGAWARA, Y., NAKAGAWA, Y. and UNO, T., 1981, A pharmacokinetic analysis program (MULTI) for microcomputer. Journal of Pharmacobio-Dynamics, 4, 879–885.
   PubMedGoogle Scholar